[Dermovate scalp application in dermatology. A multi-centre Swiss study (author's transl)].
D000293:Adolescent; D000328:Adult; D000505:Alopecia / Q000188:drug therapy; D001623:Betamethasone / Q000031:analogs & derivatives*; D002648:Child; D002675:Child, Preschool; D002990:Clobetasol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000188:drug therapy; D014677:Pharmaceutical Vehicles; D010915:Pityriasis / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012536:Scalp Dermatoses / Q000188:drug therapy*; D013557:Switzerland
D014677:Pharmaceutical Vehicles; D001623:Betamethasone; D002990:Clobetasol
Dermovate Scalp Application in der dermatologischen Praxis. Eine gesamtschweizerische Studie.